Russell Clayton

Insider Reports History

Location
Warrington, PA
Signature
/s/ Jennifer Johansson, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Russell Clayton:

Company Role Class Num Shares Value Price $ Report Date Ownership
Larimar Therapeutics, Inc. Chief Medical Officer Common Stock 71,443 $272,197 $3.81 26 Jan 2026 Direct
Larimar Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 153,822 26 Jan 2026 Direct

Insider Reports Filed by Russell Clayton

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LRMR Larimar Therapeutics, Inc. 26 Jan 2026 2 $0 4 Chief Medical Officer 27 Jan 2026, 17:04
LRMR Larimar Therapeutics, Inc. 22 Jan 2025 2 $0 4 Chief Medical Officer 24 Jan 2025, 16:16
LRMR Larimar Therapeutics, Inc. 17 Jan 2024 2 $0 4 Chief Medical Officer 19 Jan 2024, 16:31
LRMR Larimar Therapeutics, Inc. 17 Jul 2023 1 $0 4 Chief Medical Officer 18 Jul 2023, 16:15
LRMR Larimar Therapeutics, Inc. 17 Jul 2023 0 $0 3 Chief Medical Officer 18 Jul 2023, 16:13